Magazine

Issue 1-2016

Download Issue 1-2016 (pdf)

Letter from the Editor
Magnus Gisslén

EACS Conference in Barcelona
Per Lundblad

Hot lines from CROI 2016 – New drugs, classes and approaches
Christine Katlama

Antiretroviral Therapy at CROI 2016: too Little too Latte
Jose’ R Arribas

Hepatitis C virus (HCV) genotype 3 - the last treatment challenge?
Johannes Vermehren

Can NNRTIs become preferred again?
Graeme Moyle

Satellite symposiums at EACS Conference
Per Lundblad

Dapivirine: Lord of the rings?
Graeme Moyle

CROI 2016
Per Lundblad

AASLD Virology News 2015
Leo Flamholc

Notes 2016
Leo Flamholc

Issue 4-2015

Download Issue 4-2015 (pdf)

Guest Editorial: Letter from the president, European AIDS Clinical Society
Manuel Battegay

EACS Guidelines 8.0: the big reduction
José R Arribas

Lighter Antiretroviral Therapy: what ’s new from european teams?
Christine Katlama

HIV and Hepatitis Nordic Conference 2015
Per Lundblad

Satellite Symposiums at the HIV and Hepatitis Nordic Conference
Per Lundblad

Doctor, I can’t sleep!
Graeme Moyle

Notes 2015
Leo Flamholc

Issue 3-2015

Download Issue 3-2015 (pdf)

Letter from the Editor
Magnus Gisslén

The 7th Gilead Nordic Summer HIV Meeting
Eva Nordin

Three clinical trials of antiretroviral therapy at IAS 2015
José Arribas

Now is the time to start
Graeme Moyle

Risk for hepatocellular cancer in patients with cured hepatitis C
Soo Aleman

When to start? The end of an endless question
Christine Katlama

Notes 2015
Leo Flamholc

Issue 2-2015

Download Issue 2-2015 (pdf)

Letter from the Editor
Magnus Gisslén

ILC in Vienna
Per Lundblad

Efavirenz: too much of a good thing?
Jose R Arribas

The new DHHS guidelines. Forgetting evidence, embracing opinion
Graeme Moyle

Topical Conferences

New drugs from new classes of drugs
Christine Katlama

Monitoring the persistent HIV reservoir in the era of HIV cure trials
Ward de Spiegelaere and Linos Vanderkerckhove

Symposium on the search for a cure
Per Lundblad

Banishing B - going beyond management
Per Lundblad

Conquering C - going beyond cure
Per Lundblad

The new landscape in management of HCV
Per Lundblad

Notes 2015
Leo Flamholc

Issue 1-2015

Download Issue 1-2015 (pdf)

Letter from the Editor
Magnus Gisslén

CROI 2015
Per Lundblad

Hepatitis C Price war begins
Graeme Moyle

In search for better nucleos(t)ides. Is TAF the answer?
Jose Arribas

Smoking shortens life more than HIV, Hepatitis C. Varenecline may help stop
Graeme Moyle

What´s new in prevention?
Christine Katlama

Partnering for cure meeting in Stockholm
Per Lundblad

Seven novel HCV DAAs approved - confused by too many options?
Heiner Wedemeyer

Notes 2015
Leo Flamholc

Topical Conferences

Issue 4-2014

Download Issue 4-2014 (pdf)

Letter from the Editor
Magnus Gisslén

HIV Drug Therapy Congress Glasgow 2014
Per Lundblad

Where now for Protease inhibitors?
Graeme Moyle

PROTEA: the end of the road of protease inhibitor monotherapy?
José R Arribas

HIV News from Glasgow 2014
Christine Katlama

HIV Nordic Conference Stockholm 2014
Per Lundblad

Satellite Symposiums at the HIV Nordic Conference
Per Lundblad

AASLD 2014: the era of IFN-free hepatitis C treatment is entering clinical practice!
Heiner Wedemeyer

Issue 3-2014

Download Issue 3-2014 (pdf)

Letter from the Editor
Magnus Gisslén

6th Gilead Nordic Summer HIV Meeting
Per Lundblad

Nucleoside Free Zones
Graeme Moyle

SALT & OLE: ”If you can beat them, join them” (but just one of them)
José R Arribas

The 4th European Workshop on HIV Infection in the CNS (HANSA)
Aylin Yilmaz

The HCV drug-rally is ongoing: Simeprevir and Daclatasvir approved by EMA!
Heiner Wedemeyer

News from the Summer/Winter World AIDS Conference, Melbourne
Christine Katlama

Issue 2-2014

Download Issue 2-2014 (pdf)

Letter from the Editor
Magnus Gisslén

Hepatitis treatment at the ILC in London
Per Lundblad

HHS Guidelines Update: What you shouldn´t miss
José R. Arribas

Tubular alarm bells
Graeme Moyle

News from CROI & EASL on Treatment of Hepatitis C in patients with HIV
Jürgen Kurt Rockstroh

EASL 2014: The ”100 %” Melting!
The NEJM: The Hepatitis C Journal!
Heiner Wedemeyer

Integrase Inhibitors in Clinical Practice: Today and Tomorrow
Christine Katlama

Issue 1-2014

Download Issue 1-2014 (pdf)

Letter from the Editor
Magnus Gisslén
CROI 2014
Per Lundblad
NEAT 991 and ACTG 5257: sparing NUCS or NON-NUCS
José R. Arribas
Dr Graeme Moyle in UK
Per Lundblad
Drug Interactions with Intergrase Inhibitors
Graeme Moyle
The European Sofosbuvir Label: From Evidence-based to EMA-based Medicine
Heiner Wedemeyer
A Melting Pot from CROI 2014
Christine Katlama

Issue 4-2013

Download Issue 4-2013 (pdf)

HIV treatment guidelines
Magnus Gisslén

14th EACS Conference in Brussels
Per Lundblad

14th European AIDS Conference: Update on ART
José Arribas

HIV-associated lymphoma: Treatment update
Hans Hagberg

AIDS Vaccine Congress in Barcelona
Per Lundblad

The price of antiretroviral therapy
Graeme J. Moyle

HIV & Hepatitis News
Leo Flamholc

New ARV drugs: What’s in the pipeline?
Christine Katlama

The path towards IFN-free therapy of hepatitis C
Part 4: We made it! IFN-free therapy is reality!
Heiner Wedemeyer

Topical Conferences in 2014

Pages